Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124995702 | 12499570 | 2 | F | 201605 | 20160707 | 20160627 | 20160711 | EXP | DE-PFIZER INC-2016249019 | PFIZER | 5.00 | MON | F | Y | 1.50000 | KG | 20160711 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124995702 | 12499570 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Intravenous drip | 0.06 MG/KG, UNK | Y | 22473 | .06 | MG/KG | SOLUTION FOR INJECTION | ||||||
| 124995702 | 12499570 | 2 | C | ILOMEDIN | ILOPROST | 1 | Intravenous (not otherwise specified) | 6 HOURS DAILY | 0 | ||||||||||
| 124995702 | 12499570 | 3 | C | ILOMEDIN | ILOPROST | 1 | Respiratory (inhalation) | 12 X 1 UG DAILY | 0 | ||||||||||
| 124995702 | 12499570 | 4 | C | NITRIC OXIDE. | NITRIC OXIDE | 1 | Respiratory (inhalation) | UNK | 0 | ||||||||||
| 124995702 | 12499570 | 5 | C | ADRENALIN | EPINEPHRINE | 1 | Intravenous drip | APPROXIMATLEY 0.2 UG/KG/MIN | 0 | ||||||||||
| 124995702 | 12499570 | 6 | C | DOPAMINE | DOPAMINEDOPAMINE HYDROCHLORIDE | 1 | APPROXIMATELY 4 UG/KG/MIN | 0 | |||||||||||
| 124995702 | 12499570 | 7 | C | MORPHIN | MORPHINE | 1 | Intravenous drip | APPROXIMATELY 20 UG/KG/H | 0 | ||||||||||
| 124995702 | 12499570 | 8 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | APPROXIMATELY 0.2 MG/KG/H | 0 | |||||||||||
| 124995702 | 12499570 | 9 | C | VECURONIUM | VECURONIUM BROMIDE | 1 | Intravenous drip | APPROXIMATELY 0.15 UG/KG/H | 0 | ||||||||||
| 124995702 | 12499570 | 10 | C | BOSENTAN. | BOSENTAN | 1 | Oral | 1 MG/KG, 2X/DAY | 0 | 1 | MG/KG | BID | |||||||
| 124995702 | 12499570 | 11 | C | VANCOMYCIN | VANCOMYCIN | 1 | 10 MG/KG, 2X/DAY | 0 | 10 | MG/KG | BID | ||||||||
| 124995702 | 12499570 | 12 | C | MEROPENEM. | MEROPENEM | 1 | 15 MG/KG, 3X/DAY | 0 | 15 | MG/KG | TID | ||||||||
| 124995702 | 12499570 | 13 | C | PHENOBARBITAL. | PHENOBARBITAL | 1 | 0 | ||||||||||||
| 124995702 | 12499570 | 14 | C | HCT | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 124995702 | 12499570 | 15 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 | ||||||||||||
| 124995702 | 12499570 | 16 | C | CHLORALHYDRAT | 2 | 0 | |||||||||||||
| 124995702 | 12499570 | 17 | C | MILRINON | 2 | 0.375-0.75 UG/KG/MIN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124995702 | 12499570 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124995702 | 12499570 | OT |
| 124995702 | 12499570 | HO |
| 124995702 | 12499570 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124995702 | 12499570 | Hypotension | |
| 124995702 | 12499570 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124995702 | 12499570 | 1 | 20160501 | 20160505 | 0 | |
| 124995702 | 12499570 | 2 | 20160430 | 20160502 | 0 | |
| 124995702 | 12499570 | 3 | 20160430 | 0 | ||
| 124995702 | 12499570 | 4 | 20160425 | 20160506 | 0 | |
| 124995702 | 12499570 | 5 | 20160426 | 20160513 | 0 | |
| 124995702 | 12499570 | 6 | 20160425 | 20160506 | 0 | |
| 124995702 | 12499570 | 7 | 20160425 | 20160512 | 0 | |
| 124995702 | 12499570 | 8 | 20160425 | 20160515 | 0 | |
| 124995702 | 12499570 | 9 | 20160425 | 20160511 | 0 |